137Jordao JF, Thevenot E, Markham-Coultes K et al (2013) Amyloid-beta plaque reduction, endog-
enous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound.
Exp Neurol 248:16–29
Kang TW, Choi SW, Yang SR et al (2014) Growth arrest and forced differentiation of human pri-
mary glioblastoma multiformE by a novel small molecule. Sci Rep 4:5546
Kelly JJ, Stechishin O, Chojnacki A et al (2009) Proliferation of human glioblastoma stem cells
occurs independently of exogenous mitogens. Stem Cells 27(8):1722–1733
Konofagou EE, Tung YS, Choi J, Deffieux T, Baseri B, Vlachos F (2012) Ultrasound-induced
blood-brain barrier opening. Curr Pharm Biotechnol 13(7):1332–1345
Kreso A, Dick John E (2014) Evolution of the cancer stem cell model. Cell Stem Cell 14(3):275–291
Laks DR, Masterman-Smith M, Visnyei K et al (2009) Neurosphere formation is an independent
predictor of clinical outcome in malignant glioma. Stem Cells 27(4):980–987
Lapidot T, Sirard C, Vormoor J et al (1994) A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature 367(6464):645–648
Lathia JD, Gallagher J, Heddleston JM et al (2010) Integrin alpha 6 regulates glioblastoma stem
cells. Cell Stem Cell 6(5):421–432
Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CLL, Rich JN (2015) Cancer stem cells in
glioblastoma. Genes Dev 29(12):1203–1217
Lee G, Hall RR, Ahmed AU (2016) Cancer stem cells: cellular plasticity, niche, and its clinical
relevance. J Stem Cell Res Ther 6(10):363
Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S (2003) Expression of tenascin-C in
various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer
98(11):2430–2439
Leventhal C, Rafii S, Rafii D, Shahar A, Goldman SA (1999) Endothelial trophic support of neu-
ronal production and recruitment from the adult mammalian subependyma. Mol Cell Neurosci
13(6):450–464
Li Z, Bao S, Wu Q et al (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma
stem cells. Cancer Cell 15(6):501–513
Liebelt BD, Shingu T, Zhou X, Ren J, Shin SA, Hu J (2016) Glioma stem cells: signaling, micro-
environment, and therapy. Stem Cells Int 2016:7849890
Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the
central nervous system. Acta Neuropathol 114(2):97–109
Louvi A, Artavanis-Tsakonas S (2006) Notch signalling in vertebrate neural development. Nat Rev
Neurosci 7(2):93–102
Mannino M, Chalmers AJ (2011) Radioresistance of glioma stem cells: Intrinsic characteristic or
property of the ‘microenvironment-stem cell unit’? Mol Oncol 5(4):374–386
Mao XG, Xue XY, Wang L et al (2013) CDH5 is specifically activated in glioblastoma stem-
like cells and contributes to vasculogenic mimicry induced by hypoxia. Neurooncology
15(7):865–879
Mathieu J, Zhou W, Xing Y et al (2014) Hypoxia inducible factors have distinct and stage-specific
roles during reprogramming of human cells to pluripotency. Cell Stem Cell 14(5):592–605
McCord AM, Jamal M, Shankavaram UT, Lang FF, Camphausen K, Tofilon PJ (2009) Physiologic
oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells
in vitro. Mol Cancer Res 7(4):489–497
MDM I, Bonavia R, Mukasa A et al (2010) Tumor heterogeneity is an active process maintained
by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev 24(16):1731–1745
Mendez O, Zavadil J, Esencay M et al (2010) Knock down of HIF-1alpha in glioma cells reduces
migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol
Cancer 9:133
Merkle FT, Tramontin AD, Garcia-Verdugo JM, Alvarez-Buylla A (2004) Radial glia give
rise to adult neural stem cells in the subventricular zone. Proc Natl Acad Sci U S A
101(50):17528–17532
7 Glioblastoma Stem Cells and Their Microenvironment